The global oncolytic virus therapy market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of cancer and rising awareness about oncolytic viruses among physicians and patients.
Oncolytic viruses are engineered viruses that selectively infect and kill cancer cells while sparing healthy cells in the body. They are administered intravenously or intraperitoneally, depending on the type of cancer being treated. Oncolytic virus therapy is used for treating various types of cancers such as melanoma, prostate cancer, breast cancer, ovarian cancer etc, which have been resistant to conventional treatments like chemotherapy or radiation therapy.
The global oncolytic virus therapy market is segmented by type into HS-based Oncolytic Viruses, Adenovirus-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses and Newcastle Disease Virus-based Oncolysitc Viruses; by application into Melanoma Treatment (Prostate Cancer Treatment), Breast Cancer Treatment (Ovarian Cancer Treatment) and others; by region into North America (Latin America), Europe (Asia Pacific) Middle East & Africa).
-The global Oncolytic Virus Therapy market is expected to grow at a CAGR of XX% during the forecast period. -The global Oncolytic Virus Therapy market is expected to grow at a CAGR of XX% during the forecast period. -The global Oncolytic Virus Therapy market is expected to grow at a CAGR of XX% during the forecast period.
Industry Growth Insights published a new data on “Oncolytic Virus Therapy Market”. The research report is titled “Oncolytic Virus Therapy Market research by Types (HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses, Oncolytic Virus Therap), By Applications (Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others), By Players/Companies Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys, Oncolytic Virus Therap”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oncolytic Virus Therapy Market Research Report
By Type
HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses, Oncolytic Virus Therap
By Application
Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others
By Companies
Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys, Oncolytic Virus Therap
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Oncolytic Virus Therapy Market Report Segments:
The global Oncolytic Virus Therapy market is segmented on the basis of:
Types
HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses, Oncolytic Virus Therap
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amgen
- Oncolytics Biotech
- Viralytics
- Transgene SA
- Oncolys BioPharma
- Targovax
- PsiOxus Therapeutics
- SillaJen Biotherapeutics
- Sorrento Therapeutics
- Lokon Pharma
- Genelux Corporation
- Vyriad
- TILT Biotherapeutics
- Cold Genesys
- Oncolytic Virus Therap
Highlights of The Oncolytic Virus Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- HSV-based Oncolytic Viruses
- Adenoviruses-based Oncolytic Viruses
- Vaccinia Virus-based Oncolytic Viruses
- Vesicular Stomatitis Virus-based Oncolytic Viruses
- Newcastle Disease Virus-based Oncolytic Viruses
- Oncolytic Virus Therap
- By Application:
- Melanoma
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oncolytic Virus Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oncolytic virus therapy is a treatment for cancer that uses viruses to kill the cancer cells. Oncolytic viruses are specially designed to attack and destroy only the cancer cells, without harming normal tissue. This makes oncolytic virus therapy a very effective way to treat many types of cancers.
Some of the major players in the oncolytic virus therapy market are Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys, Oncolytic Virus Therap.
The oncolytic virus therapy market is expected to grow at a compound annual growth rate of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oncolytic Virus Therapy Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oncolytic Virus Therapy Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oncolytic Virus Therapy Market - Supply Chain
4.5. Global Oncolytic Virus Therapy Market Forecast
4.5.1. Oncolytic Virus Therapy Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oncolytic Virus Therapy Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oncolytic Virus Therapy Market Absolute $ Opportunity
5. Global Oncolytic Virus Therapy Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oncolytic Virus Therapy Market Size and Volume Forecast by Type
5.3.1. HSV-based Oncolytic Viruses
5.3.2. Adenoviruses-based Oncolytic Viruses
5.3.3. Vaccinia Virus-based Oncolytic Viruses
5.3.4. Vesicular Stomatitis Virus-based Oncolytic Viruses
5.3.5. Newcastle Disease Virus-based Oncolytic Viruses
5.3.6. Oncolytic Virus Therap
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oncolytic Virus Therapy Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oncolytic Virus Therapy Market Size and Volume Forecast by Application
6.3.1. Melanoma
6.3.2. Prostate Cancer
6.3.3. Breast Cancer
6.3.4. Ovarian Cancer
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oncolytic Virus Therapy Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oncolytic Virus Therapy Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oncolytic Virus Therapy Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oncolytic Virus Therapy Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oncolytic Virus Therapy Demand Share Forecast, 2019-2026
9. North America Oncolytic Virus Therapy Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oncolytic Virus Therapy Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oncolytic Virus Therapy Market Size and Volume Forecast by Application
9.4.1. Melanoma
9.4.2. Prostate Cancer
9.4.3. Breast Cancer
9.4.4. Ovarian Cancer
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oncolytic Virus Therapy Market Size and Volume Forecast by Type
9.7.1. HSV-based Oncolytic Viruses
9.7.2. Adenoviruses-based Oncolytic Viruses
9.7.3. Vaccinia Virus-based Oncolytic Viruses
9.7.4. Vesicular Stomatitis Virus-based Oncolytic Viruses
9.7.5. Newcastle Disease Virus-based Oncolytic Viruses
9.7.6. Oncolytic Virus Therap
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oncolytic Virus Therapy Demand Share Forecast, 2019-2026
10. Latin America Oncolytic Virus Therapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oncolytic Virus Therapy Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oncolytic Virus Therapy Market Size and Volume Forecast by Application
10.4.1. Melanoma
10.4.2. Prostate Cancer
10.4.3. Breast Cancer
10.4.4. Ovarian Cancer
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oncolytic Virus Therapy Market Size and Volume Forecast by Type
10.7.1. HSV-based Oncolytic Viruses
10.7.2. Adenoviruses-based Oncolytic Viruses
10.7.3. Vaccinia Virus-based Oncolytic Viruses
10.7.4. Vesicular Stomatitis Virus-based Oncolytic Viruses
10.7.5. Newcastle Disease Virus-based Oncolytic Viruses
10.7.6. Oncolytic Virus Therap
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oncolytic Virus Therapy Demand Share Forecast, 2019-2026
11. Europe Oncolytic Virus Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oncolytic Virus Therapy Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oncolytic Virus Therapy Market Size and Volume Forecast by Application
11.4.1. Melanoma
11.4.2. Prostate Cancer
11.4.3. Breast Cancer
11.4.4. Ovarian Cancer
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oncolytic Virus Therapy Market Size and Volume Forecast by Type
11.7.1. HSV-based Oncolytic Viruses
11.7.2. Adenoviruses-based Oncolytic Viruses
11.7.3. Vaccinia Virus-based Oncolytic Viruses
11.7.4. Vesicular Stomatitis Virus-based Oncolytic Viruses
11.7.5. Newcastle Disease Virus-based Oncolytic Viruses
11.7.6. Oncolytic Virus Therap
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oncolytic Virus Therapy Demand Share, 2019-2026
12. Asia Pacific Oncolytic Virus Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oncolytic Virus Therapy Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oncolytic Virus Therapy Market Size and Volume Forecast by Application
12.4.1. Melanoma
12.4.2. Prostate Cancer
12.4.3. Breast Cancer
12.4.4. Ovarian Cancer
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oncolytic Virus Therapy Market Size and Volume Forecast by Type
12.7.1. HSV-based Oncolytic Viruses
12.7.2. Adenoviruses-based Oncolytic Viruses
12.7.3. Vaccinia Virus-based Oncolytic Viruses
12.7.4. Vesicular Stomatitis Virus-based Oncolytic Viruses
12.7.5. Newcastle Disease Virus-based Oncolytic Viruses
12.7.6. Oncolytic Virus Therap
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oncolytic Virus Therapy Demand Share, 2019-2026
13. Middle East & Africa Oncolytic Virus Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oncolytic Virus Therapy Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oncolytic Virus Therapy Market Size and Volume Forecast by Application
13.4.1. Melanoma
13.4.2. Prostate Cancer
13.4.3. Breast Cancer
13.4.4. Ovarian Cancer
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oncolytic Virus Therapy Market Size and Volume Forecast by Type
13.7.1. HSV-based Oncolytic Viruses
13.7.2. Adenoviruses-based Oncolytic Viruses
13.7.3. Vaccinia Virus-based Oncolytic Viruses
13.7.4. Vesicular Stomatitis Virus-based Oncolytic Viruses
13.7.5. Newcastle Disease Virus-based Oncolytic Viruses
13.7.6. Oncolytic Virus Therap
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oncolytic Virus Therapy Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oncolytic Virus Therapy Market: Market Share Analysis
14.2. Oncolytic Virus Therapy Distributors and Customers
14.3. Oncolytic Virus Therapy Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Amgen
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Oncolytics Biotech
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Viralytics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Transgene SA
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Oncolys BioPharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Targovax
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. PsiOxus Therapeutics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. SillaJen Biotherapeutics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sorrento Therapeutics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Lokon Pharma
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Genelux Corporation
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Vyriad
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. TILT Biotherapeutics
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Cold Genesys
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Oncolytic Virus Therap
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
